Kelly Clarkson's Ex-Husband Brandon Blackstock Dead At 48 What You're Really Eating When You Order Taco Bell Helicopter ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

David Risinger, Leerink Partners senior research analyst, joins 'Power Lunch' to discuss how competitive Eli Lilly's business ...

A slew or company results were causing big market moves ahead of the opening bell Thursday, and for many, earnings-beat ...

The Dow and S&P 500 eased on Thursday, as shares of Eli Lilly dropped after data from its oral weight loss drug disappointed, ...

U.S. equities slipped midday Thursday as corporate earnings and fresh tariff announcements from President Donald Trump drove ...

Lilly’s results from an obesity pill study didn’t perform as well as Wall Street expected. It resulted in lower weight loss ...

Drugmaker Eli Lilly said Thursday that things are looking good for their latest weight loss drug that would be available as a ...

Sales grew 38% year over year, driven by volume growth from weight-loss and diabetes drugs Zepbound and Mounjaro, Lilly said.

Cancer vaccine experts are worried that if the Trump administration takes a hostile posture towards mRNA broadly, cancer ...

Lilly has been chasing—and gaining on—its chief metabolic medicine rival Novo Nordisk and its counterpart GLP-1s Ozempic and ...

The tariffs are Trump’s way of getting drug companies to move more of their operations to the U.S. at a time when domestic ...